Moran Kyle
Chief Financial Officer
Moran Kyle has filed 2 SEC Form 4 filings (13 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Feb 11, 2026.
On the most recent filing, Moran Kyle is listed as Chief Financial Officer at Wave Life Sciences Ltd. Inside the rolling window, Moran Kyle reported no open-market purchases and 3 open-market sales totaling $4.2M in WVE. The largest disclosed transaction in the window is a sale of 210,000 WVE shares on Dec 8, 2025, worth $3.1M.
Companies traded
Other insiders at WVE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Moran Kyle made?
Moran Kyle has filed 2 SEC Form 4 filings (13 transaction rows) across 1 company since 2025.
Which companies does Moran Kyle trade?
Moran Kyle has filed SEC Form 4 disclosures for 1 company, including WVE.
When was Moran Kyle's most recent SEC Form 4 filing?
Moran Kyle's most recent SEC Form 4 filing on Tracefour is dated Feb 11, 2026.
What is Moran Kyle's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Moran Kyle is listed as Chief Financial Officer.
What is Moran Kyle's total buy and sell value in the current window?
Inside the rolling retention window, Moran Kyle bought $0 and sold $4.2M based on SEC Form 4 filings.
What was Moran Kyle's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 210,000 WVE shares on 2025-12-08, worth $3.1M, per SEC Form 4 filings.